Tweets
Today, the 5 most vaccinated states (14M people) had
580 people in hospital, 12 deaths
In the 5 least vaccinated states (16M people)?
6,600 hospitalized, 104 deaths
Per capita , least vaccinated states have
10X hospitalizations and 7X deaths
So yeah, vaccines are working
Ashish K. Jha, MD, MPH @ashishkjha ( View Tweet )
5 years ago
Nice rvw of tx for SSc-ILD by @sclerodermaUM et al
Endorse: "MMF is now considered the standard of care as first line
therapy for the treatment of SSc-ILD"
Reasonable chart, but wish we could offer more HSCT
Also, I'm seeing a LOT of INappropriate early use of nintedanib https://t.co/n1R73EbrXZ
Mike Putman @EBRheum ( View Tweet )
5 years ago
Smart, concise, insightful short video by Dr Marwan Bukhari (Editor-in-Chief of Rheumatology) on how to write an abstract. https://t.co/M8AUFZsxMF
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
The TORTUGA trial tested filgotinib, a JAK1 inhibitor, in active ankylosing spondylitis (AS) patients and was shown to be both effective and capable of retarding sacroiliac (SI) joint erosions as early as 12 weeks.
https://t.co/awfZdiTUBt https://t.co/ST2JIkavhy
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
TB rarely causes arthritis; accounts for 1-5% of all TB (10-30% of pulmonary TB) cases. May present as mono/oligoarthritis, tenosynovitis, dactylitis, Spondylitis (Potts disease), reactive arthritis (Poncets dz) or polyarthritis. https://t.co/RpMrRLQbEa
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
Safety and Tolerability of Subcutaneous Methotrexate
A large, single-rheum center analysis of oral and SC MTX use in daily clinical practice suggests that SC MTX has fewer drug discontinuations and is better tolerated compared to other DMARD therapies.
https://t.co/TZwZO9j5xd https://t.co/tx9dWoHUj0
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
It was a banner week at the FDA; a new drug approval you should know about; a lot of information about pregnancy and safety; and an interesting case plus a question from one of our readers--this and more in this week's podcast. Let's dive in.
https://t.co/5K8ejJ4jj2 https://t.co/RDEM0BMZLC
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
Lumbar Spine Decompression Alone is Superior to Decompression with Fusion
https://t.co/EjLoVZaJf5 https://t.co/OJHJl3EWsv
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
Can you manage FM without opioids? Study of 698 Fibromyalgia pts from a tertiary center finds 27.1% taking opioids. Opioid associated with longer Sx duration (>3 yrs), increased age, worse functional impairment & pain catastrophizing https://t.co/N1G4ZtkUE5
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
Delays in Joint Replacement as JIA Patients Reach Adulthood
https://t.co/EQNZPD8d7o
The JIA category, year of implant, and presence of complications significantly affected implant survivorship. https://t.co/yiD74AElPC
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
FDA issued Drug Safety Communication to statin manufacturers requesting they remove strong warnings against statin use during pregnancy. While statins appear in breast milk, they should not be contraindicated, if needed, during Pregnancy https://t.co/AeFwpsLMXT
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
Pfizer has another JAK inhibitor - ritlecitinib - shown to be effective (vs PBO) in alopecia areata in the Phase 2b/3 ALLEGRO trial. Ritlecitinib is also being studied in vitiligo, rheumatoid arthritis, Crohn’s & ulcerative colitis. https://t.co/ccx0eRXuTS https://t.co/fApTP7WaYU
Links:
Dr. John Cush @RheumNow ( View Tweet )
5 years ago
